yellow fever vaccine (Beijing Institute of Biological Products)

The yellow fever live attenuated vaccine, developed by the Beijing Institute of Biological Products (BIBP), is a prophylactic vaccine used to prevent yellow fever virus infection. It utilizes the 17D-204 attenuated strain of the yellow fever virus as its active ingredient. The production process involves inoculating the working seed into 7-8 day old SPF chicken embryos, which are then incubated, harvested, and processed into a freeze-dried formulation to ensure stability. The vaccine is designed to induce a robust and long-lasting protective immune response by stimulating the production of neutralizing antibodies and activating cellular immunity. It is primarily indicated for individuals traveling to or residing in WHO-designated yellow fever endemic regions and is listed as a mandatory vaccination by Chinese entry-exit inspection and quarantine authorities for travelers to these areas.

Other names

Yellow Fever Live Attenuated Vaccine黄热减毒活疫苗Yellow Fever Vaccine (Live Attenuated)YF-17D-204 vaccineYF17D-204 vaccineYF 17D-204 vaccine